Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(600/week)
Manufacturing
(427/week)
Energy
(314/week)
Technology
(448/week)
Other Manufacturing
(344/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Inflammatory bowel disease
Oct 25, 2019
SFA Therapeutics, Inc. To Present At The Microbiome R&D and Business Collaboration Forum
Oct 17, 2019
Palatin Presents On Pl8177 Oral Colon Delivery Formulation For Ulcerative Colitis At The 7Th CPC Symposium On Peptide Therapeutics
Oct 03, 2019
Prometheus Biosciences, Inc., Enters Into Multi-Target Strategic Collaboration with Takeda to Develop Targeted Therapies for Inflammatory Bowel Disease
Oct 02, 2019
Biomica Announces Advancement to Pre-Clinical Studies in its Inflammatory Bowel Disease Program
Sep 30, 2019
Immunic, Inc. to Participate in Investor and Scientific Conferences in October
Sep 10, 2019
Intestinal Inflammation in Infants Dramatically Reduced with Bifidobacterium infantis
Sep 03, 2019
Human Microbiome Market Worth $1,731 Million by 2027 - Exclusive Report by MarketsandMarkets(TM)
Aug 30, 2019
Visiongain Report Offers Transformative Insights on the $8.6bn Inflammatory Bowel Diseases (IBD) Drug Market
Aug 28, 2019
Crohn's & Colitis Foundation's New England Chapter Commemorates 50th Anniversary of Support for Inflammatory Bowel Diseases
Aug 27, 2019
BiomX Announces In-house Phage Manufacturing Facility
Aug 14, 2019
Lilly Launches Open Innovation Challenge to Help Transform Inflammatory Bowel Disease (IBD) Care through Digital Health
Aug 12, 2019
Immunic, Inc. Announces First Patient Enrolled in Investigator-Sponsored Proof-of-Concept Clinical Trial of IMU-838 for the Treatment of Patients with Primary Sclerosing Cholangitis
Aug 01, 2019
Oral Alpha-4-Beta-7 Integrin Antagonist PN-943 Demonstrates Sustained Dose-Related Target Engagement Activity in a Multiple Ascending Dose Phase 1 Study
Jul 18, 2019
CME Outfitters to Present Findings on Effectiveness of Education on Prior Authorization in IBD at Annual ACG Conference
Jul 01, 2019
Palatin Technologies Provides Mid-Calendar Year Corporate Update
Jun 14, 2019
Reistone Announces First Patient Dosed in Two Phase II Global Studies of SHR0302 JAK Inhibitor for Ulcerative Colitis and Crohn's Disease
Jun 11, 2019
BiomX Licenses Novel Targets for Liver Disease Phage Therapy Program From JSR Corporation in Japan
Jun 03, 2019
Ulcerative Colitis: Epidemiology Forecast to 2026 - Update
May 21, 2019
Theravance Biopharma Reports Data from Phase 1b Study of TD-1473 in Oral Presentation at Digestive Disease Week (DDW) 2019
May 21, 2019
Lilly's Mirikizumab Met Primary Endpoint and Key Secondary Endpoints in Phase 2 Study, Including Reductions of Gastrointestinal Lesions
‹‹
Page 2
››
Latest News
Apr 26, 2024
Oshkosh Awarded $40M Rogue-Fires Order Ahead of MDM 2024
Apr 26, 2024
NewMarket Corporation Declares Quarterly Dividend
Apr 26, 2024
Howmet Aerospace Board Approves Common and Preferred Stock Dividends
Apr 26, 2024
Aptar Reports First Quarter 2024 Results
Apr 26, 2024
On.Energy Closes $25 Million Working Capital Facility With Lombard Odier Investment Managers
Apr 26, 2024
Orion S.A. Declares Interim Quarterly Dividend
Apr 26, 2024
Mettler-Toledo International Inc. Announces Webcast of Presentation at the BofA Securities 2024 Healthcare...
Apr 26, 2024
Snap-on Incorporated Declares Quarterly Dividend
View all News
Agenda
24
September
Hilton London Syon Park, London, UK
Defence Transformation Conference
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
View All Events